ATCC 6538 Staphylococcus Aureus, Subsp. aureus

In the world of microbiology, very few bacterial strains have gained as much renown and usefulness as Staphylococcus aureus subsp. aureus ATCC 6538. Listed in the American Type Culture Collection (ATCC) catalog as strain number 6538, this methicillin-susceptible bacterium serves as a cornerstone for quality control, antimicrobial testing, and research into bacterial pathogenesis. Isolated from a human lesion over a century ago, ATCC 6538 has transcended its humble origins to become a global standard in laboratories, ensuring the reliability of disinfectants, antibiotics, and diagnostic tools. Its enduring importance lies not only in its stability but also in its representation of a pre-antibiotic pathogen and the insights it offers into the evolution of resistance and virulence.

The story of ATCC 6538 begins in the early 20th century, a time when bacterial infections were common and antibiotics were still a distant dream. The strain was first isolated from a human skin lesion by the German physician Friedrich Rosenbach in the late 1800s, but its formal addition to the ATCC collection occurred only later, in 1937. Rosenbach, known for his work on wound infections, identified Staphylococcus aureus as a coagulase-positive coccus responsible for pus-forming abscesses. This characteristic is also seen in ATCC 6538.

In the 1940s, as penicillin emerged as a miracle drug, initial testing revealed moderate resistance in some Staphylococcus aureus isolates, including a variant known as ATCC 6538P. However, later characterizations showed this resistance to be inconsistent, highlighting the strain's susceptibility to modern standards. ATCC 6538, designated as FDA strain 209, DSM 799, WDCM 00032, and NCTC 10788, quickly became a reference for regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the World Health Organization (WHO). Its pre-antimicrobial isolation makes it invaluable for studying how Staphylococcus aureus, a leading cause of skin infections, pneumonia, and bloodstream invasions, has adapted over time.

ATCC 6538 is a Gram-positive, spherical bacterium that grows in aerobic or facultative anaerobic conditions, clustering in grape-like aggregations. It grows optimally at 37 degrees Celsius on nutrient-rich media such as tryptic soy agar or blood agar, where it forms golden-yellow colonies. This species was named aureus, from the Latin word for gold. A distinctive feature is the presence of two colony morphologies on blood agar: opaque and translucent, reflecting differences in capsule production or metabolic activity.

As a coagulase-positive strain, it produces the coagulase enzyme, which clots plasma, a key virulence factor that enables abscess formation. ATCC 6538 is a non-motile and catalase-positive bacterium, exhibiting a tendency to form biofilms on surfaces and mimicking real-world infections on medical devices. Its susceptibility profile includes methicillin, vancomycin, and most beta-lactams, but serves as a benchmark for emerging resistances.

The true strength of ATCC 6538 lies in its role as a quality control tool. In antimicrobial susceptibility testing, its consistent response to biocides such as quaternary ammonium compounds and alcohols makes it the gold standard for evaluating disinfectants under standards such as ASTM E1053 and EN 1040. Laboratories worldwide use ATCC 6538 to validate culture media, dyes, reagents, and identification kits, and to provide reproducible results in clinical diagnostics.

In drug development, databases such as ATCC 6538 and Antimicrobial Index provide detailed minimum inhibitory concentration data for compounds against this strain, thus testing antibiotic efficacy. Genome sequencing has supported studies on the evolution of biocide resistance by revealing mutations in efflux pumps and membrane proteins that Staphylococcus aureus uses to survive in harsh environments.

Researchers are also using this method in virulence models, from mouse skin infection analyses to in vitro biofilm disruption tests, by investigating how toxins such as alpha-hemolysin contribute to tissue damage.

ATCC commercially offers this strain in a variety of formats: freeze-dried vials, glycerol stocks, and mini-packages containing barcoded, ready-to-use aliquots for high-throughput laboratories.

ATCC 6538's century-old legacy underscores the importance of reference strains in linking historical microbiology with modern challenges. As antibiotic resistance increases (methicillin-resistant Staphylococcus aureus claims thousands of lives each year), it provides a baseline for tracking these subtle ancestral genomic changes. Future research could leverage regulatory frameworks for its sequenced genome to develop vaccines targeting Staphylococcus aureus outbreaks in hospitals or to design models for phage therapy.

In an era of global health threats, ATCC 6538 is key to understanding the past and tackling the future. From routine quality control to cutting-edge genomic studies, this humble bacterium continues to shed light on the obscure world of staphylococcal infections.

For many years, our organization, with its competent and experienced staff, has been understanding the needs of its clients, providing the advanced testing services they require, and assisting in the establishment, implementation, and improvement of management systems. Within this framework, we also provide testing services to businesses in accordance with the “ATCC 6538 Staphylococcus aureus, subsp. aureus” standard.